Amivantamab-Chemotherapy in Non-Small Cell Lung Cancer with EGFR Exon 20 Insertions: Impact of Treatment Crossover and Other Endpoints from the Phase III PAPILLON Study. - Sanborn RE; Zhou C; Tang KJ; Cho BC; Cheng S; Popat S; Ono A; Lu S; Majem M; Aguilar A; Del Rosario Garcia Campelo M; Hayashi H; et al. (Targeted oncology, 2025)